Cadrenal Therapeutics(CVKD) - 2023 Q1 - Quarterly Report

Item 1. Legal Proceedings 24 FORM 10-Q For the quarterly period ended March 31, 2023 For the transition period from to | --- | --- | |--------------------------------------------------|-----------------------| | Delaware | 88-0860746 | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 822 A1A North, Suite 306 | | | Ponte Vedra, Florida | 32082 | | (Address of principal executive offices) | (Zip Code) | | --- | --- | --- | |--------------------- ...